BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 17222357)

  • 1. Noonan syndrome.
    van der Burgt I
    Orphanet J Rare Dis; 2007 Jan; 2():4. PubMed ID: 17222357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical symptoms and molecular pathogenesis of Noonan syndrome--current concepts].
    Klapecki J; Obersztyn E; Laniewski-Wollk M; Szpecht-Potocka A; Mazurczak T
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):289-308. PubMed ID: 17028394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.
    Tartaglia M; Mehler EL; Goldberg R; Zampino G; Brunner HG; Kremer H; van der Burgt I; Crosby AH; Ion A; Jeffery S; Kalidas K; Patton MA; Kucherlapati RS; Gelb BD
    Nat Genet; 2001 Dec; 29(4):465-8. PubMed ID: 11704759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noonan syndrome. A review.
    Cesur Aydin K; Ozcan I
    Minerva Pediatr; 2008 Jun; 60(3):343-6. PubMed ID: 18487980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noonan syndrome: introduction and basic clinical features.
    Rohrer T
    Horm Res; 2009 Dec; 72 Suppl 2():3-7. PubMed ID: 20029230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
    Lee ST; Ki CS; Lee HJ
    Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G; Neuer K; Ranke MB; Wittekindt NE
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning.
    Schollen E; Matthijs G; Gewillig M; Fryns JP; Legius E
    Eur J Hum Genet; 2003 Jan; 11(1):85-8. PubMed ID: 12529711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene.
    Sznajer Y; Keren B; Baumann C; Pereira S; Alberti C; Elion J; Cavé H; Verloes A
    Pediatrics; 2007 Jun; 119(6):e1325-31. PubMed ID: 17515436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype correlations in Noonan syndrome.
    Zenker M; Buheitel G; Rauch R; Koenig R; Bosse K; Kress W; Tietze HU; Doerr HG; Hofbeck M; Singer H; Reis A; Rauch A
    J Pediatr; 2004 Mar; 144(3):368-74. PubMed ID: 15001945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noonan syndrome.
    Turner AM
    J Paediatr Child Health; 2014 Oct; 50(10):E14-20. PubMed ID: 21771153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
    Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
    Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of Noonan syndrome: a long-term follow-up study.
    Shaw AC; Kalidas K; Crosby AH; Jeffery S; Patton MA
    Arch Dis Child; 2007 Feb; 92(2):128-32. PubMed ID: 16990350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and variation in phenotype in Noonan syndrome.
    Jongmans M; Otten B; Noordam K; van der Burgt I
    Horm Res; 2004; 62 Suppl 3():56-9. PubMed ID: 15539800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the rare A172G mutation of PTPN11 gene convey a mild Noonan syndrome phenotype?
    Kitsiou-Tzeli S; Papadopoulou A; Kanaka-Gantenbein C; Fretzayas A; Daskalopoulos D; Kanavakis E; Nicolaidou P
    Horm Res; 2006; 66(3):124-31. PubMed ID: 16804314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune liver disease in Noonan Syndrome.
    Loddo I; Romano C; Cutrupi MC; Sciveres M; Riva S; Salpietro A; Ferraù V; Gallizzi R; Briuglia S
    Eur J Med Genet; 2015 Mar; 58(3):188-90. PubMed ID: 25595571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTPN11 mutations and genotype-phenotype correlations in Noonan and LEOPARD syndromes.
    Ogata T; Yoshida R
    Pediatr Endocrinol Rev; 2005 Jun; 2(4):669-74. PubMed ID: 16208280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
    Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
    BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome.
    Musante L; Kehl HG; Majewski F; Meinecke P; Schweiger S; Gillessen-Kaesbach G; Wieczorek D; Hinkel GK; Tinschert S; Hoeltzenbein M; Ropers HH; Kalscheuer VM
    Eur J Hum Genet; 2003 Feb; 11(2):201-6. PubMed ID: 12634870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome.
    Yoshida R; Hasegawa T; Hasegawa Y; Nagai T; Kinoshita E; Tanaka Y; Kanegane H; Ohyama K; Onishi T; Hanew K; Okuyama T; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3359-64. PubMed ID: 15240615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.